Enhanced antibody-mediated cellular cytotoxicity of germline-like anti-HER2 antibodies through a point mutation in complementarity-determining regions
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf063 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Guangyu Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: MoE Frontiers Science Center for Precision Oncology, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Complementarity Determining Regions, Antibody-Dependent Cell Cytotoxicity, Point Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Science and Technology Development Fund of Macau, University of Macau.
Abstract (Originalsprache)
Human epidermal growth factor receptor 2 (HER2) is highly overexpressed on the surface of breast cancer cells, presenting an attractive target for therapeutic antibodies. Antibody-dependent cellular cytotoxicity (ADCC) is a central mechanism underlying the antitumor activities of anti-HER2 monoclonal antibodies. Here, we engineered Ab5, a germline-like anti-HER2 monoclonal antibody derived from a naïve human antibody library. Our aim was to enhance the ADCC properties of Ab5 by affinity maturation. Through an in silico aided mutagenesis analysis, we identified an Ab5 mutant termed Ab5m, exhibiting enhanced affinity compared with the parental Ab5. Computational modeling predicted that a crucial interacting residue, aspartic acid 31 on the complementarity-determining region 1 of the heavy chain involved in the important charged interactions with HER2 domain II. Substitution of aspartic acid with glutamic acid decreased the interaction energies, resulting in a remarkable affinity enhancement of Ab5m-scFv (KD = 0.2 nM) compared with parental Ab5-scFv (KD = 1.5 nM). This affinity maturation translated into the obvious improvement in ADCC and notable enhancement of tumor ablation in vivo, either alone or in combination with anti-B7-H3 antibodies. These findings suggest that the potential of affinity optimization as a strategy to enhance the ADCC properties of human germline antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MoE Frontiers Science Center for Precision Oncology, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China.
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
- Department of Radiology, Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
- Fred Wyszkowski Cancer Research Laboratory, Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel.
- State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
ORCID-Profile: Yuheng Gu, Bihui Cao, Defang Ouyang, Qi Zhao
Förderung
- Natural Science Foundation of Guangdong Province
- Science and Technology Development Fund of Macau
- University of Macau
Zitieren
APA
Zhou, G., Zhang, Y., Gu, Y., Cao, B., Fan, X., Yu, D., Fu, S., Liu, M., Assaraf, Y. G., Li, Y., Ouyang, D., & Zhao, Q. (2025). Enhanced antibody-mediated cellular cytotoxicity of germline-like anti-HER2 antibodies through a point mutation in complementarity-determining regions. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf063
Vancouver
Zhou G, Zhang Y, Gu Y, Cao B, Fan X, Yu D, et al. Enhanced antibody-mediated cellular cytotoxicity of germline-like anti-HER2 antibodies through a point mutation in complementarity-determining regions. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf063
BibTeX
@article{Zhou2025,
author = {Zhou, Guangyu and Zhang, Yunsen and Gu, Yuheng and Cao, Bihui and Fan, Xin and Yu, Di and Fu, Shengyu and Liu, Manting and Assaraf, Yehuda G and Li, Yaping and Ouyang, Defang and Zhao, Qi},
title = {Enhanced antibody-mediated cellular cytotoxicity of germline-like anti-HER2 antibodies through a point mutation in complementarity-determining regions},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf063}
}
EUVIMED